Please login to the form below

Not currently logged in
Email:
Password:

Amitiza

This page shows the latest Amitiza news and features for those working in and with pharma, biotech and healthcare.

Lilly’s Efient and Sucampo's Amitiza win NICE backing

Lilly’s Efient and Sucampo's Amitiza win NICE backing

NICE, which provides healthcare recommendations to the NHS, issued new guidance on the use of Sucampo Pharma Europe's Amitiza (lubiprostone) for adults with chronic idiopathic constipation and updated its view ... The Amitiza recommendation follows

Latest news

  • NICE backs constipation treatment NICE backs constipation treatment

    Sucampo’s Amitiza set for NHS use in England and Wales.  . Sucampo's constipation treatment Amitiza (lubiprostone) should be available on the NHS, according to new healthcare guidance. ... Amitiza has been available in the UK since December last, but

  • AZ drug for opioid constipation starts FDA review AZ drug for opioid constipation starts FDA review

    Naloxegol on course to compete with Takeda’s Amitiza. AstraZeneca (AZ) took a step closer to securing US approval for its new candidate for opioid drug-induced constipation (OIC) after the ... Sucampo reported Amitiza sales of a little over $80m in

  • An unexpected turn

    Lubiprostone. Amitiza (Takeda Pharmaceuticals). Irritable Bowel Syndrome. US. Mycophenolate mofetil (Cellcept; Roche) is an immunosupressant commonly used for treating and preventing transplant rejection.

  • Sucampo moves on EU market

    US pharmaceutical company, Sucampo, has launched a bid to compete in the European marketplace by filing a marketing authorisation application in Switzerland for its drug, Amitiza. ... Nine other EU countries are currently reviewing MAAs for Amitiza,

  • IBS drug approved in the US

    The US Food and Drug Administration has approved Amitiza for an additional indication to treat irritable bowel syndrome with constipation. ... The US Food and Drug Administration (FDA) has approved Amitiza for an additional indication to treat irritable

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...